Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (171-180 of 420) with videos related to

Pageof 42
Sort By:
Diagnostic Microbiology and Infectious Disease|December 21, 2002
Salmonella spp. isolates causing bloodstream infections in Latin America: report of antimicrobial activity from the SENTRY Antimicrobial Surveillance Program (1997-2000)Ana C Gales, Helio S Sader, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|February 8, 2014
Activity of oritavancin tested against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwideRodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|March 4, 2008
Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infectionsThomas R Fritsche, Paul R Rhomberg, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|October 6, 2006
Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005)Lalitagauri M Deshpande, Paul R Rhomberg, Helio S Sader, et al.
BMC Infectious Diseases|April 20, 2007
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)Helio S Sader, Amy A Watters, Thomas R Fritsche, et al.
The Journal of Antimicrobial Chemotherapy|January 9, 2004
Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001)Alan H Mutnick, Paul R Rhomberg, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy|April 13, 2011
Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance studyRonald N Jones, David J Farrell, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2012
Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programRobert K Flamm, Helio S Sader, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2014
Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010David J Farrell, Robert K Flamm, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2018
Antimicrobial Activity of Murepavadin Tested against Clinical Isolates of Pseudomonas aeruginosa from the United States, Europe, and ChinaHelio S Sader, Glenn E Dale, Paul R Rhomberg, et al.
Pageof 42

Showing results (171-180 of 420) with videos related to

Sort By:
Pageof 42
Diagnostic Microbiology and Infectious Disease|December 21, 2002
Salmonella spp. isolates causing bloodstream infections in Latin America: report of antimicrobial activity from the SENTRY Antimicrobial Surveillance Program (1997-2000)Ana C Gales, Helio S Sader, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|February 8, 2014
Activity of oritavancin tested against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwideRodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|March 4, 2008
Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infectionsThomas R Fritsche, Paul R Rhomberg, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|October 6, 2006
Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005)Lalitagauri M Deshpande, Paul R Rhomberg, Helio S Sader, et al.
BMC Infectious Diseases|April 20, 2007
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)Helio S Sader, Amy A Watters, Thomas R Fritsche, et al.
The Journal of Antimicrobial Chemotherapy|January 9, 2004
Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001)Alan H Mutnick, Paul R Rhomberg, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy|April 13, 2011
Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance studyRonald N Jones, David J Farrell, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2012
Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programRobert K Flamm, Helio S Sader, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2014
Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010David J Farrell, Robert K Flamm, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2018
Antimicrobial Activity of Murepavadin Tested against Clinical Isolates of Pseudomonas aeruginosa from the United States, Europe, and ChinaHelio S Sader, Glenn E Dale, Paul R Rhomberg, et al.
Pageof 42